What is Castle Biosciences's earnings yield?

Castle Biosciences (CSTL) reported earnings yield of -1.8% in Q1 2026.

How has Castle Biosciences's earnings yield changed year-over-year?

Castle Biosciences's earnings yield decreased by 98.0% year-over-year, from -0.9% to -1.8%.

What is the long-term trend for Castle Biosciences's earnings yield?

Over 5 years (2020 to 2025), Castle Biosciences's earnings yield has grown at a 28.6% compound annual growth rate (CAGR), from -0.6% to -2.1%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Castle Biosciences CSTL Earnings yield

Earnings yield at other companies

Labcorp HoldingsLH

4.3%+0.5pp

VeracyteVCYT

3.4%+2.0pp

Myriad GeneticsMYGN

-95%-112pp

Personalis, Inc.PSNL

-14.3%-4.6pp

NeoGenomicsNEO

-10.3%+16.7pp

Fulgent Genetics, Inc.FLGT

-14.9%+136pp

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Calculated from Castle Biosciences’s reported figures.

net income/market cap=-1.8%

Based on trailing twelve months.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's earnings yield?: Castle Biosciences (CSTL) reported earnings yield of -1.8% in Q1 2026.
How has Castle Biosciences's earnings yield changed year-over-year?: Castle Biosciences's earnings yield decreased by 98.0% year-over-year, from -0.9% to -1.8%.
What is the long-term trend for Castle Biosciences's earnings yield?: Over 5 years (2020 to 2025), Castle Biosciences's earnings yield has grown at a 28.6% compound annual growth rate (CAGR), from -0.6% to -2.1%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.